The First Health Industry Summit and the 74th China International Pharmaceutical API, Intermediates, Packaging and Equipment Trade Fair to Bloom in May at China National Convention and Exhibition Center (Shanghai) The first Health Industry Summit (TheHealthIndustrySummit,tHIS) with the theme of "Integration - New Power of Health Industry" will be held on May 15-18, 2015 at the brand new China National Convention and Exhibition Center (Shanghai) in Hongqiao, Shanghai. The summit will be the first of its kind to integrate the three major exhibitions in the field of pharmaceutical, medical and healthcare industry chain - CMEF (Medical Fair), PharmChina (Pharmaceutical Fair), and APIChina (Ingredients Fair). tHIS Summit's breakthroughs and innovations will promote the integration of China's healthcare industry and improve its development level.

　　Three Exhibition Brands Combine Efforts to Create Scale

　　According to Reed Sinopharm, the first tHIS Summit integrates more than 100 thematic conferences and a 260,000-square-meter international exhibition, which will centrally display tens of thousands of high-quality and cost-effective medical equipments, pharmaceutical products, APIs, and other related products and services from 6,000 selected exhibitors from all over the world, and create a new platform for the 150,000 professional visitors from 140 countries in the areas of trade cooperation, academic discussion, business expansion, experience sharing, etc. The Summit will also provide an opportunity to promote the development of China's healthcare industry. The exhibition will create a brand new platform for 150,000 professional visitors from 140 countries in terms of trade cooperation, academic discussion, business development and experience sharing.

　　The 74th Reed Sinopharm China International Trade Fair for Pharmaceutical APIs, Intermediates, Packaging and Equipment

　　Taking advantage of Reed Sinopharm's three major exhibitions in the field of healthcare gathering in Shanghai, the 74th China International Pharmaceutical API, Intermediates, Packaging and Equipment Fair attracted the participation of many overseas buyers. As of early April, the number of overseas buyers registered has exceeded 2,000. A total of 13 countries from India, South Korea, Pakistan, Japan, Thailand, Vietnam, France, Germany, Finland, Hungary, Ukraine, Kazakhstan, Brazil and other countries in the pharmaceutical industry buyer groups to participate in this exhibition. At the same time, the number of buyers from Hong Kong, Taiwan and Macao also reached a record high. According to the introduction of the organizing committee of the exhibition, the conference set up more than 600 square meters of quiet and comfortable environment of overseas buyers leisure negotiation area, equipped with dozens of professional interpreters and industry experts, for the Chinese local enterprises and overseas customers to communicate and negotiate to provide strong support. At the same time, the exhibition also attracted the attention and participation of many multinational pharmaceutical companies. Purchasing, quality and technical personnel from Pfizer, Bayer, Novartis, AstraZeneca, Merck, Thermo Fisher, Boehringer Ingelheim, Merck Sharp & Dohme, and other famous multinational pharmaceutical companies will appear in this exhibition. It can be said that "international style" will be the change of the 74th China International Pharmaceutical API, Intermediates, Packaging and Equipment Fair compared with the past.

　　APIChina - people-oriented, caring for health, and promote the sustainable development of the industry

　　China's pharmaceutical industry API enterprises, after more than 60 years of development, has experienced the production of bulk basic APIs, the production of APIs for the original research enterprise and independent research and development and production of specialty APIs of the three stages of the transformation, APIChina witnessed the history of the API industry evolution process, in this stage cohesion of China's APIs people's dreams and hopes. At the same time, along with the development of China's pharmaceutical industry, APIChina has been sharpening and growing day by day and year by year. In order to meet the needs of China's pharmaceutical and healthcare enterprises for industrial upgrading, various special zones have been created.

　　CRO/CMO Zone brings together domestic and foreign enterprises, focusing on the display of pharmaceutical R&D, outsourcing services in the field of advanced products and technologies, to provide technical support for the development of China's pharmaceutical industry, the scene will also interact with the R & D area of the National Pharmaceutical Trade Fair, and jointly present CRO & CMO forums and conferences in the form of a "meeting" and "exhibition" linkage to set up a platform for communication and exhibition for enterprises, witnessing the industrial upgrading of the pharmaceutical industry.

　　As a professional natural extracts zone in China, Natural Extracts Zone focuses on providing raw materials for preparation, health food, food and cosmetic enterprises. On the one hand, as a sub-industry in the field of traditional Chinese medicine with the possibility of internationalization, the state has continuously strengthened the regulation of the industry in recent years, which will surely force the quality of products to be upgraded; on the other hand, the review of the registration of health food products may be changed into a filing system, which will bring about a spurt in the natural extracts market, which will lead to an increase in the demand for natural extracts. Natural extracts market blowout, it can be said that the natural extracts area has become a flagship brand casting pharmaceutical industry, to promote the catalyst for industrial upgrading. With Huayao Group, Shanghai Pharmaceutical Group, Harbin Pharmaceutical Group, Shandong Xinhua, Sinopharm Group, Qilu Pharmaceutical, Puluo Pharmaceutical, Jinyao Group, Tonglian Pharmaceutical, Erkang Pharmaceutical, Kelun Pharmaceutical, Huahai Pharmaceutical, Haizheng Pharmaceutical and other domestic and foreign well-known APIs, intermediates, excipients, chemicals, natural extracts enterprises.